tyrosine and Dysplastic Nevus Syndrome, Hereditary

tyrosine has been researched along with Dysplastic Nevus Syndrome, Hereditary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Qiao, S; Wang, H; Wang, T1
Fan, YF; Ge, GB; Hou, FB; Pan, QS; Qian, XK; Wang, P; Xiang, YW; Zhao, DF; Zhu, SX1
Bernardes, SS; Cecchini, AL; Cecchini, R; da Silva, CF; de Souza-Neto, FP; Derossi, DR; Guarnier, FA; Melo, GP; Ramalho, LN; Simão, AN1

Reviews

1 review(s) available for tyrosine and Dysplastic Nevus Syndrome, Hereditary

ArticleYear
Spectrophotometric Assays for Sensing Tyrosinase Activity and Their Applications.
    Biosensors, 2021, Aug-23, Volume: 11, Issue:8

    Topics: Biosensing Techniques; Humans; Kinetics; Melanoma; Melanoma, Cutaneous Malignant; Monophenol Monooxygenase; Oxidation-Reduction; Skin Neoplasms; Spectrophotometry; Tyrosine

2021

Other Studies

2 other study(ies) available for tyrosine and Dysplastic Nevus Syndrome, Hereditary

ArticleYear
Dysregulated ceramides metabolism via PTPN11 exposes a metabolic vulnerability to breast cancer metastasis.
    Medical oncology (Northwood, London, England), 2023, Sep-29, Volume: 40, Issue:11

    Topics: Breast Neoplasms; Ceramides; Female; Humans; Lipid Metabolism; Melanoma, Cutaneous Malignant; Neoplasms, Second Primary; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases, Non-Receptor; Protein-Tyrosine Kinases; Tyrosine

2023
Systemic oxidative profile after tumor removal and the tumor microenvironment in melanoma patients.
    Cancer letters, 2015, Jun-01, Volume: 361, Issue:2

    Topics: Adult; Aged; Female; Humans; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Oxidative Stress; Skin Neoplasms; Tumor Microenvironment; Tyrosine; Young Adult

2015